Skip to main content
Clinical Trials/NCT04991428
NCT04991428CompletedNot Applicable

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1

University of Manchester1 site in 1 country31 target enrollmentStarted: February 22, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
31
Locations
1
Primary Endpoint
Corsi Block task

Study Overview

Brief Summary

Intellectual impairment, particularly working memory deficits are a significant cause of morbidity in children with Neurofibromatosis type (NF1) with long-term implications on academic and occupational functioning. Whilst significant discoveries have been made in Nf1 animal models in trying to find treatments for these conditions, human translational studies have not been successful. This mechanistic experimental study will investigate the neural mechanisms underlying working memory deficits in NF1. In particular, we will investigate how individual differences in inhibitory neurotransmitter GABA relate to performance on working memory tests. Further, we will investigate the use of a novel, experimental intervention called transcranial Direct Current Stimulation (tDCS);known to modulate GABA. Using a randomized, crossover design in a cohort of 30 adolescents aged 11-17 years, we will apply real or sham tDCS to the dorsolateral prefrontal cortex (DLPFC). State-of-art real time imaging techniques such as Magnetic Resonance Spectroscopy (MRS) and task based functional MRI (fMRI) will be used to investigate the effect of tDCS on GABA concentration, changes in functional plasticity and working memory. We expect that results from this study will help elucidate the neural mechanisms underlying working memory deficits in people with NF1 and show biologic activity for a novel, low-cost intervention that can be used for cognitive remediation in NF1. This kind of focused mechanism trial method is a highly promising approach to understanding the complex neural system pathology in a multifactorial neurodevelopmental condition like NF1.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Single (Participant)

Eligibility Criteria

Ages
11 Years to 17 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Meets National Institute of Health NF1 diagnostic criteria
  • •Children aged 11-17 years
  • •Written informed consent/assent

Exclusion Criteria

  • •No history of intracranial pathology other than asymptomatic optic pathway glioma or other asymptomatic and untreated NF1-associated white matter lesion
  • •No history of epilepsy or any major mental illness
  • •No MRI contraindications.

Arms & Interventions

Sham stimulation

Sham Comparator

Similar set-up but no actual stimulation

Intervention: Transcranial direct current stimulation (Other)

Active trancranial direct current stimulation

Experimental

Active stimulation for 15 minutes

Intervention: Transcranial direct current stimulation (Other)

Outcomes

Primary Outcomes

Corsi Block task

Time Frame: immediately after the intervention

memory span task

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr Shruti Garg

Clinical Senior Lecturer

University of Manchester

Study Sites (1)

Loading locations...

Similar Trials